Yaneng Bioscience (Shenzhen) Co., Ltd.
私たちについて
Leading the Molecular Diagnostics Market in China for 21 years.
Since 2001, Yaneng BIOscience (Shenzhen) Co., Ltd. developed the first gene chip in China, YanengBIO has taken the leading position in the Molecular diagnostics market in China through 20 years of development and continuous innovation. YanengBIO have established the leading position in the Molecular diagnostics market in China. At present, the company has about 600 employees, among which the R&D department led by Ph.D team accounts for more than 20%.
At present, our core products, HPV and Thalassemia projects, have occupied No.1 place in the Chinese market, with sales revenue CAGR of 24% and annual R&D expenditure 18%.
Talent Team
Professional & Brilliant teams: 11 PhDs, 5 talents of Peacock Plan. R&D technicians accounted for 1/5. Undergraduate or above employees accounted for 50%. Average age of the team is 32 years old.
Three major R&D technology centers: Enterprise postdoctoral workstation. Tumor liquid biopsy technological service platform. Gene chip engineering research center.
私たちの価値観
Mission: Develop Molecular Diagnostics,and Benefit Human Health.
Vision: R&D can make every laboratory enjoy the finest service brought by high-quality IVD products.
Value: Innovation drives R&D, works with agility.
